A Phase 4 interventional study of Metaxalone 640 mg Oral Tablet in Sciatica Acute and Lumbar Spinal Stenosis, sponsored by Primus Pharmaceuticals. Recruiting at 24 sites in United States. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-14.
Sponsored by Primus Pharmaceuticals · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 151 studies in Spinal Stenosis with a site in United States — 27 open to participants now, 32 under way, 2 of them phase 3. Spinal Stenosis · United States.
Among the 151 studies in Spinal Stenosis with a site in United States, this one is the 63rd largest by planned enrollment of the 110 interventional ones that give a count, is one of 7 that started in 2023, is one of 19 in phase 4, reaches primary completion later than 11 of the 31 other live ones, and was the 140th registered.
460 studies on the registry are indexed under Spinal Stenosis; 107 are open to participants now.
Browse Spinal Stenosis studies →27 of the 151 studies in Spinal Stenosis with a site in United States are open now. Recruiting first, the newest first:
Brigham and Women's Hospital · Sites in United States
Ages 40–85
EicOsis Human Health Inc. · Sites in United States
Ages 18+
VA Office of Research and Development · Sites in United States
Ages 55–80
Spinal Simplicity LLC · Sites in United States
Ages 18+
Dartmouth-Hitchcock Medical Center · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 66 Spinal Stenosis studies recruiting now, 30 (45%) set no upper age limit and 9 (14%) stop at 75 or younger; 2 take children under 18; 6 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
151 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 8 · Phase 2 10 · Phase 3 10 · Phase 4 19
First in 2000; this study’s year is marked. 7 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 50 is below the median of 80 across 282 interventional studies indexed under Spinal Stenosis.
Median enrollment 60 across the 110 interventional studies, 200 across the 41 observational. Of the 96 that completed or were terminated, 41 (43%) have results posted.
This tab as a report to print or save as PDF → With an account.
59 of 151 have an industry lead sponsor. The 10 most frequent:
Primus Pharmaceuticals is the lead sponsor of 21 studies on the registry; 4 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 5 (83%) have results posted.
Primus Pharmaceuticals has 1 study filed under Spinal Stenosis — fewer than ten, so there is no comparison to draw.
9 of the studies in Spinal Stenosis with a site in United States that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06140927Phase 3University of California, San FranciscoEffect of Ketamine on Intraoperative Motor Evoked Potentials | 2026-12-01 |
| NCT05058287Phase 3Hospital for Special Surgery, New YorkLumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression | 2026-12-31 |
| NCT03072927Stryker InstrumentsMILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study | 2026-12 |
| NCT04992572Stanford UniversityStudy Comparing Local/ MAC Anesthesia in Lumbar Decompression | 2026-12-31 |
| NCT06089746VA Office of Research and DevelopmentLumbosacral Spinal Stenosis - Non-Invasive Postural Therapy for Older Adult Veterans | 2027-01-31 |
Add all 9 to your calendar (.ics) → With an account.
Among the 151 studies in Spinal Stenosis with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to learn if a modification to metaxalone 640 mg can reduce low back and leg pain. The participants will be 18 to 80 years old, healthy with newly occurring back or leg pain. The main question aims to compare a group taking active treatment and a group taking a look-alike substance containing no active treatment. All participants will answer questions on Day 1, before treatment, and on 7-day after treatment, about:
Double-blind, randomized, placebo-controlled, multi-center study of metaxalone 640 mg plus standard of care for patients with acute lumbo sacral musculoskeletal conditions with spinal stenosis and sciatica. Participants will be randomized 1:1. Following the initial pilot-study a second study will randomize a larger population of patients with appropriate power.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Clinically significant
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Metaxalone micronized 640 mg over encapsulated tablet Taken orally every 6 hours for 7 days
Drug: Metaxalone 640 mg Oral Tablet
Inactive placebo capsule 640 mg Taken orally every 6 hours for 7 days
Drug: Metaxalone 640 mg Oral Tablet
Metaxalone 640 mg used for the treatment of discomforts associated with acute, musculoskeletal pain.
Also known as: Skelaxin un-micronized, M640, metaxalone micronized
Change of Numeric Pain Scale
Change from Baseline in low back pain and leg pain as measured by the Numeric Pain Rating Scale (NPRS) at Day 7
Time frame: Day 1 to Day 7
Not enrolling at this site — choose another above.
Not enrolling at this site — choose another above.
Not enrolling at this site — choose another above.
Not enrolling at this site — choose another above.
Not enrolling at this site — choose another above.
Not enrolling at this site — choose another above.
Not enrolling at this site — choose another above.
Not enrolling at this site — choose another above.
Not enrolling at this site — choose another above.
Not enrolling at this site — choose another above.
Not enrolling at this site — choose another above.
Not enrolling at this site — choose another above.
Not enrolling at this site — choose another above.
Not enrolling at this site — choose another above.
Not enrolling at this site — choose another above.
Not enrolling at this site — choose another above.
Plan to share: No
No publications or documents are linked to this record.
Started Nov 2023 (actual). Primary completion is estimated for Nov 2026, 36 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Metaxalone
Primus Pharmaceuticals